Evidence map›Paper›PMID 39801257›Full record

ArticleCancer communications (London, England)2025

Targeting ferroptosis resistance resensitizes metastatic HR

Charles Pottier, Laetitia Montero-Ruiz, Robin Jehay, Coline Wery, Dominique Baiwir, Gabriel Mazzucchelli, Sophie Bekisz, Romain Thissen, Claire Josse, Andrée Rorive and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Ferroptosis and its role in immune modulation in breast cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Charles PottierCancer Metabolism and Tumor Microenvironment Group, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Laetitia Montero-RuizCancer Metabolism and Tumor Microenvironment Group, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Robin JehayCancer Metabolism and Tumor Microenvironment Group, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Coline WeryCancer Metabolism and Tumor Microenvironment Group, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Dominique BaiwirProteomics Facility, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0002-1622-0118
Gabriel MazzucchelliProteomics Facility, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Sophie BekiszBiomechanics Research Unit, In silico Medicine, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Romain ThissenHuman Genetics Department, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Claire JosseHuman Genetics Department, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.
Andrée RoriveMedical Oncology Department, University Hospital of Liège, Liège, Belgium.
Stéphanie GofflotBiobank of the University Hospital of Liège, University of Liège, Liège, Belgium.
Ahmed DahmaniLaboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France.
Ludivine MorissetLaboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France.
Joëlle CollignonMedical Oncology Department, University Hospital of Liège, Liège, Belgium.
Philipe DelvenneAnatomie et cytologie pathologiques, University Hospital of Liège, Liège, Belgium.
Elisabetta MarangoniLaboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France.
Agnès NoëlLaboratory of Tumor and Development Biology, Interdisciplinary Group for Applied Genoproteomics (GIGA) Appliquée, University of Liège, Liège, Belgium.
Guy JerusalemMedical Oncology Department, University Hospital of Liège, Liège, Belgium.
Nor Eddine SounniCancer Metabolism and Tumor Microenvironment Group, Interdisciplinary Group for Applied Genoproteomics (GIGA), University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-9962-9236

Funding

Crédits sectoriels of the University of Liege FSR-S-SS-22/61;FSR-S-SS-22/64(NES)Foundation Contre le Cancer, Belgium FCC-2022-181(NESandAN)National Fund for Scientific Research (NFSR-FNRS) Belgium J.0178.22(NES)National Fund for Scientific Research (NFSR-FNRS) Belgium PDRNational Fund for Scientific Research (NFSR-FNRS) Belgium T.023020;CDR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39801257
PMCPMC11999879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.